KOVE medical key facts
as of Oct 2026- Developer of an implantable device designed to close the hole created by the catheter in the fetal membrane during fetoscopy.
- KOVE medical is valued at approximately $10.4M as of Oct 2026 (last reported valuation).
- It has raised $780K; the latest was Later Stage VC ($620K) in Jul 2025.
- Notable investors include Venture Kick, N & V Capital, Tech4Eva, University of Zürich.
- Status: Privately Held (backing).
KOVE medical's last reported valuation, Jul 2025. Nothing priced has surfaced since.
- ·Watch KOVE medical: the Monday email on marks, rounds and moves
KOVE medical funding rounds
No funding rounds for KOVE medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs KOVE medical
4KOVE medical valuation
KOVE medical's last reported valuation was $10.4 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.
KOVE medical investors
4 investors are on record for KOVE medical, including Venture Kick, N & V Capital, Tech4Eva and University of Zürich.
About KOVE medical
Developer of an implantable device designed to close the hole created by the catheter in the fetal membrane during fetoscopy. The company prevents membrane rupture by closing and securing the hole created by the endoscopes used to treat fetuses during pregnancy, enabling doctors to undergo more fetal treatment and reduce the risk of preterm birth.
- Sector
- Healthcare
- HQ
- Zurich, Switzerland
- Founded
- 2019
- Employees
- 7
- Website
- kovemedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.